Works matching IS 13479032 AND DT 2023 AND VI 114 AND IP 1


Results: 31
    1
    2

    Nucleic acid–triggered tumoral immunity propagates pH‐selective therapeutic antibodies through tumor‐driven epitope spreading.

    Published in:
    Cancer Science, 2023, v. 114, n. 1, p. 321, doi. 10.1111/cas.15596
    By:
    • Furuya, Genta;
    • Katoh, Hiroto;
    • Atsumi, Shinichiro;
    • Hashimoto, Itaru;
    • Komura, Daisuke;
    • Hatanaka, Ryo;
    • Senga, Shogo;
    • Hayashi, Shuto;
    • Akita, Shoji;
    • Matsumura, Hirofumi;
    • Miura, Akihiro;
    • Mita, Hideaki;
    • Nakakido, Makoto;
    • Nagatoishi, Satoru;
    • Sugiyama, Akira;
    • Suzuki, Ryohei;
    • Konishi, Hiroki;
    • Yamamoto, Asami;
    • Abe, Hiroyuki;
    • Hiraoka, Nobuyoshi
    Publication type:
    Article
    3
    4

    Retraction.

    Published in:
    Cancer Science, 2023, v. 114, n. 1, p. 339, doi. 10.1111/cas.15626
    Publication type:
    Article
    5
    6
    7
    8
    9

    Clinical impact of bile‐derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers.

    Published in:
    Cancer Science, 2023, v. 114, n. 1, p. 295, doi. 10.1111/cas.15597
    By:
    • Yoshida, Michihiro;
    • Yukawa, Hiroshi;
    • Hayashi, Kazuki;
    • Naitoh, Itaru;
    • Miyabe, Katsuyuki;
    • Hori, Yasuki;
    • Natsume, Makoto;
    • Jinno, Naruomi;
    • Kato, Akihisa;
    • Kachi, Kenta;
    • Asano, Go;
    • Sahashi, Hidenori;
    • Toyohara, Tadashi;
    • Kuno, Kayoko;
    • Kito, Yusuke;
    • Kondo, Hiromu;
    • Hirano, Atsuyuki;
    • Okumura, Fumihiro;
    • Anbe, Kaiki;
    • Baba, Yoshinobu
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    Novel hKDR mouse model depicts the antiangiogenesis and apoptosis‐promoting effects of neutralizing antibodies targeting vascular endothelial growth factor receptor 2.

    Published in:
    Cancer Science, 2023, v. 114, n. 1, p. 115, doi. 10.1111/cas.15594
    By:
    • Cao, Yuan;
    • Sun, Chunyun;
    • Huo, Guitao;
    • Wang, Huiyu;
    • Wu, Yong;
    • Wang, Fei;
    • Liu, Susu;
    • Zhai, Shijie;
    • Zhang, Xiao;
    • Zhao, Haoyang;
    • Hu, Meiling;
    • Gu, Wenda;
    • Yang, Yanwei;
    • Wang, Sanlong;
    • Liang, Chunnan;
    • Lyu, Jianjun;
    • Lu, Tiangong;
    • Wang, Youchun;
    • Xie, Liangzhi;
    • Fan, Changfa
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23

    First‐in‐human study of ONO‐4578, an antagonist of prostaglandin E<sub>2</sub> receptor 4, alone and with nivolumab in solid tumors.

    Published in:
    Cancer Science, 2023, v. 114, n. 1, p. 211, doi. 10.1111/cas.15574
    By:
    • Iwasa, Satoru;
    • Koyama, Takafumi;
    • Nishino, Makoto;
    • Kondo, Shunsuke;
    • Sudo, Kazuki;
    • Yonemori, Kan;
    • Yoshida, Tatsuya;
    • Tamura, Kenji;
    • Shimizu, Toshio;
    • Fujiwara, Yutaka;
    • Kitano, Shigehisa;
    • Shimomura, Akihiko;
    • Sato, Jun;
    • Yokoyama, Fumiharu;
    • Iida, Hiroyuki;
    • Kondo, Maki;
    • Yamamoto, Noboru
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31

    Issue Information.

    Published in:
    Cancer Science, 2023, v. 114, n. 1, p. 1, doi. 10.1111/cas.15403
    Publication type:
    Article